REGISTERED CHARITY NUMBER: 1010090
Report of the Trustees and
Unaudited Financial Statements
for the Year Ended 5 April 2023
for
CLINICAL RESEARCH TRUST
Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB
Report of the Trustees for the Year Ended 5 April 2023
CLINICAL RESEARCH TRUST
The trustees present their report with the financial statements of the charity for the year ended 5 April 2023. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
OBJECTIVES AND ACTIVITIES
Objectives and aims
The object ives of the Trust is the promotion of Clinical and Fundamental Research into the causes and treatment of clinical diseases on terms that the results of such research are published..
Current activities
The Clinical Research Trust has moved its support to the work undertaken by the Norwich Medical School in the University of East Anglia. The research has focused on work to improve the knowledge of the pathogenesis of the condition, characterisation of toxic epitopes in wheat and method to measure these cereals in foods to individuals with coeliac disease.
The Trust continues to improve the treatment and provide a better understanding of the condition and the pathogenesis to help the 670,000 affected subjects in the UK, including children and millions more worldwide to improve not only their treatment, but also to improve their quality of life.
FINANCIAL REVIEW
Reserves policy
The Trust maintains a reserve sufficient to meet its annual demands.
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
The charity is controlled by its governing document, a deed of trust and constitutes an unincorporated charity.
Risk management
The trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error.
REFERENCE AND ADMINISTRATIVE DETAILS
Registered Charity number
1010090
Principal address
25 Penzance Street Holland Park London W11 4QX
Page 1
CLINICAL RESEARCH TRUST
Report of the Trustees
for the Year Ended 5 April 2023
Trustees
Professor E K Sikora Professor P J Ciclitira
Independent Examiner
Miss Francine Hamilton Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB Approved by order of the board of trustees on 29 July 2024 and signed on its behalf by:
Professor P J Ciclitira - Trustee
Page 2
Independent Examiner's Report to the Trustees of Clinical Research Trust
Independent examiner's report to the trustees of Clinical Research Trust
I report to the charity trustees on my examination of the accounts of Clinical Research Trust (the Trust) for the year ended 5 April 2023.
Responsibilities and basis of report
As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act').
I report in respect of my examination of the Trust's accounts carried out under Section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under Section 145(5)(b) of the Act.
Independent examiner's statement
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Miss Francine Hamilton
Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB
29 July 2024
Page 3
CLINICAL RESEARCH TRUST
Statement of Financial Activities for the Year Ended 5 April 2023
| Notes INCOME AND ENDOWMENTS FROM Donations and legacies |
2023 2022 Unrestricted fund Total funds £ £ 40,636 27,166 |
|---|---|
| EXPENDITURE ON Charitable activities Grants Other |
40,829 27,140 - (24) |
| Total | 40,829 27,116 |
| NET INCOME/(EXPENDITURE) RECONCILIATION OF FUNDS Total funds brought forward |
(193) 50 1,397 1,347 |
| TOTAL FUNDS CARRIED FORWARD | 1,204 1,397 |
The notes form part of these financial statements
Page 4
CLINICAL RESEARCH TRUST
Balance Sheet 5 April 2023
| Notes FIXED ASSETS Investments 4 CURRENT ASSETS Cash at bank CREDITORS Amounts falling due within one year 5 |
2023 Unrestricted fund £ 2,160 4 (960) |
2022 Total funds £ 2,160 5 (768) |
2022 Total funds £ 2,160 5 (768) |
|---|---|---|---|
| NET CURRENT ASSETS | (956) | (763) | |
| TOTAL ASSETS LESS CURRENT LIABILITIES | 1,204 | 1,397 | |
| NET ASSETS | 1,204 | 1,397 | |
| FUNDS 6 Unrestricted funds |
1,204 | 1,397 | |
| TOTAL FUNDS | 1,204 | 1,397 |
The financial statements were approved by the Board of Trustees and authorised for issue on 29 July 2024 and were signed on its behalf by:
P J Ciclitira - Trustee
The notes form part of these financial statements
Page 5
CLINICAL RESEARCH TRUST
Notes to the Financial Statements for the Year Ended 5 April 2023
1. ACCOUNTING POLICIES
Basis of preparing the financial statements
The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention, with the exception of investments which are included at market value.
Financial reporting standard 102 - reduced disclosure exemptions
The charity has taken advantage of the following disclosure exemption in preparing these financial statements, as permitted by FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland':
- the requirements of Section 7 Statement of Cash Flows.
Income
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.
Expenditure
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.
Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure.
Taxation
The charity is exempt from tax on its charitable activities.
Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.
continued...
Page 6
CLINICAL RESEARCH TRUST
Notes to the Financial Statements - continued for the Year Ended 5 April 2023
1. ACCOUNTING POLICIES - continued
Fund accounting
Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.
2. TRUSTEES' REMUNERATION AND BENEFITS
There were no trustees' remuneration or other benefits for the year ended 5 April 2023 nor for the year ended 5 April 2022.
Trustees' expenses
There were no trustees' expenses paid for the year ended 5 April 2023 nor for the year ended 5 April 2022.
3. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
| INCOME AND ENDOWMENTS FROM Donations and legacies |
Unrestricted fund £ 27,166 |
|---|---|
| EXPENDITURE ON Charitable activities Grants Other |
27,140 (24) |
| Total | 27,116 |
| NET INCOME RECONCILIATION OF FUNDS Total funds brought forward |
50 1,347 |
| TOTAL FUNDS CARRIED FORWARD | 1,397 |
continued...
Page 7
CLINICAL RESEARCH TRUST
Notes to the Financial Statements - continued
for the Year Ended 5 April 2023
----- Start of picture text -----
4. FIXED ASSET INVESTMENTS
Listed
investments
£
MARKET VALUE
At 6 April 2022 and 5 April 2023 2,160
NET BOOK VALUE
At 5 April 2023 2,160
At 5 April 2022 2,160
There were no investment assets outside the UK.
5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£ £
Trade creditors - 840
Other creditors 960 (72)
960 768
6. MOVEMENT IN FUNDS
Net
movement
At 6/4/22 in funds At 5/4/23
£ £ £
Unrestricted funds
General fund 1,397 (193) 1,204
TOTAL FUNDS 1,397 (193) 1,204
----- End of picture text -----
continued...
Page 8
CLINICAL RESEARCH TRUST
Notes to the Financial Statements - continued for the Year Ended 5 April 2023
6. MOVEMENT IN FUNDS - continued
Net movement in funds, included in the above are as follows:
| Incoming resources £ Unrestricted funds General fund 40,636 |
Resources expended £ (40,829) |
Movement in funds £ (193) |
|---|---|---|
| TOTAL FUNDS 40,636 |
(40,829) | (193) |
| Comparatives for movement in funds At 6/4/21 £ Unrestricted funds General fund 1,347 |
Net movement in funds £ 50 |
At 5/4/22 £ 1,397 |
| TOTAL FUNDS 1,347 |
50 | 1,397 |
| Comparative net movement in funds, included in the above are as follows: Incoming resources £ Unrestricted funds General fund 27,166 |
Resources expended £ (27,116) |
Movement in funds £ 50 |
| TOTAL FUNDS 27,166 |
(27,116) | 50 |
continued...
Page 9
CLINICAL RESEARCH TRUST
Notes to the Financial Statements - continued for the Year Ended 5 April 2023
6. MOVEMENT IN FUNDS - continued
A current year 12 months and prior year 12 months combined position is as follows:
| At 6/4/21 £ Unrestricted funds General fund 1,347 |
Net movement in funds £ (143) |
At 5/4/23 £ 1,204 |
|---|---|---|
| TOTAL FUNDS 1,347 |
(143) | 1,204 |
A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:
| Unrestricted funds General fund |
Incoming Resources resources expended £ £ 67,802 (67,945) |
Movement in funds £ (143) |
|---|---|---|
| TOTAL FUNDS | 67,802 (67,945) |
(143) |
7. RELATED PARTY DISCLOSURES
There were no related party transactions for the year ended 5 April 2023.
Page 10
CLINICAL RESEARCH TRUST
Detailed Statement of Financial Activities
for the Year Ended 5 April 2023
| INCOME AND ENDOWMENTS Donations and legacies Donations Total incoming resources EXPENDITURE Charitable activities Grants to institutions Support costs Finance Sundries Governance costs Accountancy Total resources expended Net (expenditure)/income |
2023 £ 40,636 40,636 39,120 611 1,098 40,829 (193) |
2022 £ 27,166 27,166 27,173 879 (936) 27,116 50 |
|---|---|---|
This page does not form part of the statutory financial statements
Page 11
Contents of the Financial Statements for the Year Ended 5 April 2023
CLINICAL RESEARCH TRUST
----- Start of picture text -----
Page
Report of the Trustees 1 to 2
Independent Examiner's Report 3
Statement of Financial Activities 4
Balance Sheet 5
Notes to the Financial Statements 6 to 10
Detailed Statement of Financial Activities 11
----- End of picture text -----